Abstract:Background: Follicular helper T cells are a subset of helper T cells that facilitate B-cell recruitment and maturation. Rare cases of cutaneous T-cell lymphoma manifesting as de novo tumor lesions in intertriginous skin contain an infiltrate rich in B cells. These cases may represent malignant counterparts of skin-homing follicular helper T cells. Observations: Two men and 1 woman (age range, 35-58 years) were seen with predominantly intertriginous tumorstage cutaneous T-cell lymphoma lesions characterized by … Show more
“…[23][24][25] It has been postulated that the expression of CD10 differentiates systemic from cutaneous lymphomas, but evidence indicating some cases of CD10 + MF and CD4 + SMLPD denies this correlation. 24 Some recent papers have described a subset of cases of "intertriginous MF" 26,27 with an aggressive course and a TFH phenotype, particularly an intertriginous variant of MF expressing TFH markers (CD10 + , PD1 + ) that progressed to SS within 2 years. 26 However, although these cases share the clinical localisation and some of the histopathological and phenotypical features of our case, it would be too speculative to correlate this phenotypical presentation with prognosis.…”
The association between acanthosis nigricans (AN) and mycosis fungoides (MF) has rarely been described, but it is known that MF may appear as AN‐like vegetating and papillomatous plaques in skin folds, or may be associated with paraneoplastic AN. There have also been recent descriptions of a form of “intertriginous MF” that is characterized by skin fold involvement and the expression of T follicular helper (TFH) markers, and that often has an aggressive course. We describe the case of a 48‐year‐old man affected by MF associated with AN, whose lesions were characterized by a TFH immunophenotype and the expression of the GATA‐3 nuclear master regulator that may be related to a TFH‐2 subpopulation or possible disease progression.
“…[23][24][25] It has been postulated that the expression of CD10 differentiates systemic from cutaneous lymphomas, but evidence indicating some cases of CD10 + MF and CD4 + SMLPD denies this correlation. 24 Some recent papers have described a subset of cases of "intertriginous MF" 26,27 with an aggressive course and a TFH phenotype, particularly an intertriginous variant of MF expressing TFH markers (CD10 + , PD1 + ) that progressed to SS within 2 years. 26 However, although these cases share the clinical localisation and some of the histopathological and phenotypical features of our case, it would be too speculative to correlate this phenotypical presentation with prognosis.…”
The association between acanthosis nigricans (AN) and mycosis fungoides (MF) has rarely been described, but it is known that MF may appear as AN‐like vegetating and papillomatous plaques in skin folds, or may be associated with paraneoplastic AN. There have also been recent descriptions of a form of “intertriginous MF” that is characterized by skin fold involvement and the expression of T follicular helper (TFH) markers, and that often has an aggressive course. We describe the case of a 48‐year‐old man affected by MF associated with AN, whose lesions were characterized by a TFH immunophenotype and the expression of the GATA‐3 nuclear master regulator that may be related to a TFH‐2 subpopulation or possible disease progression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.